Aurora Cannabis Inc vs Charles River Laboratories Intl. Inc — how do they compare? Aurora Cannabis Inc trades at $3.4 (market cap $223.59M), while Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 60.2× Aurora Cannabis Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | CRL | |
|---|---|---|
Market Cap | $223.59M | $13.46B |
Sector | Health | Health |
52-Week High | $6.23 | $282.00 |
52-Week Low | $2.58 | $145.57 |
Enterprise Value | $168.09M | $16.30B |
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →